Interaction Between Sympk and Oct4 Promotes Mouse Embryonic Stem Cell Proliferation

Stem Cells
Jianping YuJunjiu Huang

Abstract

The scaffold protein Symplekin (Sympk) is involved in cytoplasmic RNA polyadenylation, transcriptional modulation, and the regulation of epithelial differentiation and proliferation via tight junctions. It is highly expressed in embryonic stem cells (ESCs), in which its role remains unknown. In this study, we found Sympk overexpression in mouse ESCs significantly increased colony formation, and Sympk deletion via CRISPR/Cas9 decreased colony formation. Sympk promoted ESC growth and its overexpression sustained ESC pluripotency, as assessed by teratoma and chimeric mouse formation. Genomic stability was preserved in these cells after long-term passage. The domain of unknown function 3453 (DUF3453) in Sympk was required for its interaction with the key pluripotent factor Oct4, and its depletion led to impaired colony formation. Sympk activated proliferation-related genes and suppressed differentiation-related genes. Our results indicate that Sympk interacts with Oct4 to promote self-renewal and pluripotency in ESCs and preserves genome integrity; accordingly, it has potential value for stem cell therapies. Stem Cells 2019;37:743-753.

References

Aug 1, 1996·The Journal of Cell Biology·B H KeonW W Franke
Jan 7, 2004·The Journal of Biological Chemistry·Hongyan XingKevin D Sarge
Sep 3, 2005·Molecular Cell·Xiaoyuan He, Claire Moore
Oct 10, 2007·Molecular and Cellular Biology·Vasupradha VethanthamJames L Manley
Jun 23, 2009·Development·Ian Chambers, Simon R Tomlinson
Jul 7, 2009·Journal of Molecular Biology·Sarah A KennedyMatthew R Redinbo
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·K R StevensC E Murry
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael BuchertFrédéric Hollande
Sep 9, 2010·Molecular and Cellular Biology·Kathryn M CappellAngelique W Whitehurst
May 25, 2011·Stem Cells·Brenton R PaolellaMark A Israel
Nov 16, 2011·Cell Research·Junjun DingJianlong Wang
Apr 6, 2012·Differentiation; Research in Biological Diversity·Dana Ann A TamashiroYusuke Marikawa
Jan 22, 2014·The Journal of Cell Biology·Uri WeissbeinUri Ben-David
Oct 3, 2015·Cell Stem Cell·Aleksandra A KolodziejczykSarah A Teichmann
Dec 15, 2015·Biotechnology Journal·Mohammad M MovahedniaTong Cao
Dec 22, 2016·Cellular and Molecular Life Sciences : CMLS·Chen-Yun ChenPatrick C H Hsieh
Oct 22, 2017·Free Radical Biology & Medicine·Cheng-Kai WangJean Lu

❮ Previous
Next ❯

Citations

Aug 27, 2021·Frontiers in Cell and Developmental Biology·Rui WuMengcheng Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.